Round co-led by new investors, Kurma Partners and Angelini Ventures, with significant participation from existing investors EDBI, ClavystBio, and Boehringer Ingelheim Venture Fund ...

MassBio CEO Kendalle Burlin O’Connell said that without "policy stability and renewed investment," we will cede leadership in ...

The Indian government is refining biosimilar drug regulations, aligning with global standards to ensure stringent quality in ...

Stephen Giroux is the owner of Wurlitzer Family Pharmacy in North Tonawanda and six other mom and pop pharmacies in an ...

Federal agencies, including the FDA and the EPA, were ordered to accelerate approval of domestic manufacturing plants.

President Trump stated on Monday that he intends to introduce pharmaceutical tariffs within the next two weeks, marking a ...

President Donald Trump on Monday signed an executive order to incentivize prescription drug manufacturing in the U.S., ...

From cozy relationships to blockbuster approvals, a new FDA policy promises transparency after decades of industry ...

President Donald Trump is targeting the pharmaceutical industry as a way to help finance his tax cut plans, pressing House Republicans to force drugmakers to accept lower prices on drugs covered by ...

The chemical industry is highly globalized and relies on cross-border sourcing and processing. Due to sourcing challenges, ...

The FDA is asking some of its recently fired staff responsible for critically important funding negotiations with drugmakers ...